| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/31/2003 | US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis |
| 07/31/2003 | US20030143687 Biologic variability of asthma associated factors useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 07/31/2003 | US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 07/31/2003 | US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein |
| 07/31/2003 | US20030143679 Genes encoding insect odorant receptors and uses thereof |
| 07/31/2003 | US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/31/2003 | US20030143660 Genes have been isolated from Rhodococcus and Deinococcus which encode a specific lycopene beta -cyclase capable of converting acyclic carotenoids with atleast one psi-end group to corresponding asymetric caratenoid |
| 07/31/2003 | US20030143658 Culturing then incubating with chromogen; antibiotic-free; for testing potable water |
| 07/31/2003 | US20030143657 For identification of fungicides which affect biosynthesis of l-leucine; drug screening |
| 07/31/2003 | US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents |
| 07/31/2003 | US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation |
| 07/31/2003 | US20030143651 Fret protease assays for clostridial toxins |
| 07/31/2003 | US20030143648 Enzyme activity profiles |
| 07/31/2003 | US20030143645 Screening for compounds amenable to treatment with chloroquine-based drugs; fusion proteins; antimalarial, antiarthritic and/or anti-lupus agents; stem cells |
| 07/31/2003 | US20030143642 Secretions of proteins by encapsulated cells |
| 07/31/2003 | US20030143640 Method for conducting receptor-ligand association reaction and reactor used therefor |
| 07/31/2003 | US20030143635 Assay for detection of transferase enzyme activity in drug screening |
| 07/31/2003 | US20030143631 Localized in mitochondria; enzyme inhibitors; kits |
| 07/31/2003 | US20030143629 Comprises polypeptide semiconductors which relay fluorescent/luminescent signals when binding moieties/analytes; neutralizes anthrax spores in combination with radiation |
| 07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/31/2003 | US20030143622 Human RNA binding proteins |
| 07/31/2003 | US20030143621 Contacting a cellular component with a reagent which binds to PC-1 (prostate cancer-1) protein |
| 07/31/2003 | US20030143620 Carbohydrate ligands specific for MHC molecules |
| 07/31/2003 | US20030143619 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 07/31/2003 | US20030143616 Addressable protein arrays |
| 07/31/2003 | US20030143614 Easier preparation of probes without attaching them to a fixed support, allow the use of larger number and differnt types of probes, improve hybridization and enzymatic kinetics relatie to solid-phase hybridization |
| 07/31/2003 | US20030143613 Protein expression profiling |
| 07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
| 07/31/2003 | US20030143610 Methods for the treatment of metabolic disorders, including obesity and diabetes |
| 07/31/2003 | US20030143609 Method of identifying a gene product |
| 07/31/2003 | US20030143608 Drug response marker in beta-1 adrenergic receptor gene |
| 07/31/2003 | US20030143606 Nucleic acid comprising sequence segment of chemically pretreated DNA |
| 07/31/2003 | US20030143605 Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations |
| 07/31/2003 | US20030143604 Polymerase chain reaction (PCR); use in detecting the presence of a target polynucleotide in a sample; protective agents (bovine serum albumin) |
| 07/31/2003 | US20030143602 Useful as probes and primers for amplification and sequencing; fluorescent labeling |
| 07/31/2003 | US20030143601 Methods and compositions for the detection of bovine pregnancy which utilize members of the 1-8 family of interferon inducible genes |
| 07/31/2003 | US20030143600 Extraction; use in identifying, diagnosing, monitoring, or evaluating cancer; gel electrophoresis, hybridization, blot analysis, liquid chromatography |
| 07/31/2003 | US20030143599 Attaching a primer; ligation of an adaptor sequence or homopolymeric tailing with terminal deoxynucleotidyltransferase |
| 07/31/2003 | US20030143598 Bioconjugate-nanoparticle probes |
| 07/31/2003 | US20030143595 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 07/31/2003 | US20030143594 Probes labeled with energy transfer coupled dyes |
| 07/31/2003 | US20030143593 Producing probes that are representative of a population of nucleic acids; incubation mixture of RNA and reverse transcriptase |
| 07/31/2003 | US20030143592 DNA chip |
| 07/31/2003 | US20030143591 Measuring change in fluorescence upon hybridization |
| 07/31/2003 | US20030143590 Polynucleotide encoding a polypeptide; use in treating obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorder, schizophrenia, autism, neurodegenerative disorders |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143587 Nucleic acid amplification |
| 07/31/2003 | US20030143586 Genetic hypermutability of plants for gene discovery and diagnosis |
| 07/31/2003 | US20030143585 Solid-phase reactions |
| 07/31/2003 | US20030143584 Methods for detecting rare polymorphic variants in genomic DNA sequences |
| 07/31/2003 | US20030143581 Target analyte supported on conductive support containing a nanoparticle comprising a photoelectrochemically active group, exposing the active group with light to generate photoelectric current, measuring the current |
| 07/31/2003 | US20030143580 Rapid and sensitive detection of molecules |
| 07/31/2003 | US20030143578 Stably transfecting a population of cells with a gene- trap vector, identifying cells with a trapped gene, distributing sorted cells into matrix format, pooling cells from matrix into discrete pools, producing cDNA sequence tag |
| 07/31/2003 | US20030143577 High fidelity DNA polymerase compositions and uses therefor |
| 07/31/2003 | US20030143575 Method and system for the simultaneous and multiple detection and quantification of the hybridization of molecular compounds such as nucleic acids, dna rna, pna, and proteins |
| 07/31/2003 | US20030143574 Method for analysing the length of a nucleic acid molecule |
| 07/31/2003 | US20030143572 Based upon the particular patient's genotype. A PCR kit and/or a gene chip detects multiple genes, expressions and/or mutations associated with a particular cancer using a sample of patient's tissue or blood, a detector and a computer |
| 07/31/2003 | US20030143571 Infectious disease microarray |
| 07/31/2003 | US20030143570 A solid support comprising immobilized latent thiol groups, activating the thiol groups and reacting activated thiol groups with an affinity ligand having atleast an alpha-beta unsaturated carbonyl group, immobizing ligand on the support |
| 07/31/2003 | US20030143569 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 07/31/2003 | US20030143563 Method for identifying a nucleic acid |
| 07/31/2003 | US20030143562 Structurally biased random peptide libraries based on different scaffolds |
| 07/31/2003 | US20030143560 Mutant DNA encoding peroxisome proliferator-activated receptor-gamma coactivator-1 |
| 07/31/2003 | US20030143558 Methods for attenuation of virulence in bacteria |
| 07/31/2003 | US20030143557 Useful in identifying molecules, that bind TRPM4b (transmembrane channel polypeptides) which modulate TRPM4b ion channel activity, and/or which alter expression of TRPM4b within cells |
| 07/31/2003 | US20030143556 Nucleic acid reactions using labels with different redox potentials |
| 07/31/2003 | US20030143555 Method for labeling and fragmenting DNA |
| 07/31/2003 | US20030143554 Method of genotyping by determination of allele copy number |
| 07/31/2003 | US20030143553 Nucleic acid amplification with direct sequencing |
| 07/31/2003 | US20030143552 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
| 07/31/2003 | US20030143549 Method for DNA sequencing and gene identification |
| 07/31/2003 | US20030143548 Determining genotype of the promoter region of a patient's 5-HTTP gene, and correlating with patient responsiveness; treating diarrhea-predominant irritable bowel syndrome |
| 07/31/2003 | US20030143547 Cis element to which a transcription factor is capable of binding, a promoter 3' relative to the cis element, and a reporter sequence 3' relative to the promoter |
| 07/31/2003 | US20030143546 Breast cancer transcription factor gene and uses |
| 07/31/2003 | US20030143545 Isolation of the lamin gamma2 gene in horses and its use in diagnostic junctional epidermolysis bullosa |
| 07/31/2003 | US20030143544 Diagnosis and treatment of vascular disease |
| 07/31/2003 | US20030143543 Genetic changes in atypical nodular proliferations in congenital melanocytic nevi |
| 07/31/2003 | US20030143539 Polynucleotide sequences or subsequences library that are underexpressed or overexpressed in tumor cells |
| 07/31/2003 | US20030143538 Oligonucleotides are attached to nanoparticles and have sequences complementary to portions of a nucleic acid; hybridization causes a detectable change |
| 07/31/2003 | US20030143537 Genetic polymorphisms responsible for altered expression of the cytochrome (cyp3a5); drug metabolism, efficacy and toxicity with respect to anticancer agents and immunosuppressants |
| 07/31/2003 | US20030143536 Mixing a set of primers with a target sample; incubating the primer-target sample mixture to hybridize; mixing DNA polymerase with the primer-target sample mixture; incubating the polymerase- target sample mixture to promote replication |
| 07/31/2003 | US20030143535 Nucleic acid accessible hybridization sites |
| 07/31/2003 | US20030143534 Probes for myctophid fish and a method for developing the same |
| 07/31/2003 | US20030143532 Method for producing biochemical analysis data and apparatus used therefor |
| 07/31/2003 | US20030143531 Detection and quantification of microorganisms using amplification and restriction enzyme analysis |
| 07/31/2003 | US20030143530 Method for the detection of influenza a/b viruses |
| 07/31/2003 | US20030143529 Detection and typing of human papillomavirus using PNA probes |
| 07/31/2003 | US20030143527 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis B viral DNA |
| 07/31/2003 | US20030143526 Recombinanr hhv8 dna |
| 07/31/2003 | US20030143525 Methods for nucleic acid manipulation |
| 07/31/2003 | US20030143524 Method and system for determining the amount, distribution and conformation of genetic material in a cell |
| 07/31/2003 | US20030143522 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/31/2003 | US20030143520 Determining a multidimensional shape space for components of a biochemical system in a reference state, perturbing, determining a perturbed multidimensional shape and identifying a coordinate point corresponding to a component |
| 07/31/2003 | US20030143519 Apparatus and method for evaluating tissue engineered biological material |
| 07/31/2003 | US20030143241 For inhibiting hepatitis E virus (HEV) infection |
| 07/31/2003 | US20030143232 Incubating survivin and p34cdc2-cyclin B1 kinase complex in presence of an agent; determining whether agent modulates phosphorylation of survivin by p34cdc2-cyclin B1 kinase complex, identifying an agent which modulates phosphorylation |
| 07/31/2003 | US20030143231 Assaying the ability of the compound to modulate 57749 nucleic acid expression or 57749 polypeptide activity, thereby identifying a compound capable of treating a pain disorder |
| 07/31/2003 | US20030143223 Modulating the activity of one or more elements in the complement/lipid pathway |